MedTrace Logo

Organ Preservation in Locally Advanced Rectal Cancer

NCT03064646 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-09-27

No results posted yet for this study

Summary

PRONAR trial aims to assess if treatment with organ preservation in stage II and III rectal cancer after a complete or almost complete response to neoadjuvant treatment is feasible and safe in our environment.

The main objective of this project is to implement the organ preservation strategy in the treatment of rectal cancer in our environment within a clinical study that allows the analysis of its results in terms of survival.

The secondary objective is to assess local relapse, distant relapse and quality of life.

Conditions

  • LOCALLY ADVANCED RECTAL CANCER

Interventions

OTHER

Organ Preservation

Patients with a complete response or a almost complete response after neoadjuvant treatment will be offered an organ preservation strategy

Sponsors & Collaborators

  • Hospital General Universitario Elche

    collaborator OTHER

  • Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

    lead OTHER

Principal Investigators

  • Javier Gallego, PhD · Hospital General Universitario de Elche

  • Javier Gallego, PhD · Hospital General Universitario de Elche

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-10
Primary Completion
2022-02-28
Completion
2027-02-28

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03064646 on ClinicalTrials.gov